Skip to content

Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor

Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03863392
Enrollment
100
Registered
2019-03-05
Start date
2018-06-15
Completion date
2019-03-15
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Vaginal Delivery

Brief summary

Induction of labour at term is a common obstetric intervention. Induction of labour is the artificial initiation of labour before its spontaneous onset for the purpose of delivery of the fetoplacental unit using mechanical or pharmacological methods. To determine the effects of oral misoprostol solution compared to vaginal misoprostol in induction of labour.

Detailed description

Patients recruited in the study will be primigravida at term with obstetric or medical indication for labour induction. These patients will be either booked attending antenatal clinic referred for induction of labour or emergency admissions in labour room. A total of 100 women will be randomly selected for the study. I. Women will be given 20 ml (20 µg) of misoprostol solution orally every 2 hourly until adequate uterine contractions occurred (3 contractions per 10 min lasting 30-40 s). II. The induction regimen included application of Vagiprost 25 µg tablet in the posterior fornix of the vagina every 4 h (up to 6 doses) after determination of the Bishop score.

Interventions

DRUGMisoprostol

induction of labor

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Primigravida or Primipara * Pregnancy between 36 and 42 weeks of gestation. * A live singleton fetus in cephalic presentation. * No history of uterine surgery. * Clinically adequate pelvis. * Modified Bishop's score \<5. * Reactive Non stress test (NST) .

Exclusion criteria

* •Known hypersensitivity or contraindications to oral misoprostol (uterine surgery). * Any antenatal medical complications. * A situation requiring LSCS (Maternal or Fetal) e.g:fetal distress * Non-reactive NST. * Patient's refusal to give consent

Design outcomes

Primary

MeasureTime frame
•Induction-delivery time2 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026